🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Newcastle
Clinical trial register · Australia

Clinical Trials in Newcastle, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3331 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
3331
Studies in scope
all four open statuses
1807
Recruiting now
open to new participants
758
Lead sponsors
across recruiting studies
Top sites
Melbourne 1087 Adelaide 564 Sydney 508 Westmead 416 Clayton 409
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Melbourne3 Atom Therapeutics Co., Ltd3 Eli Lilly and Company2 GlaxoSmithKline2 Breast Cancer Trials, Australia and New Zealand2
Site location
Melbourne1087 Adelaide564 Sydney508 Westmead416 Clayton409
All 397 locations
Target enrolment
to

Trials with a site in Newcastle

60 of 3331 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers
NCT07545122Triple Negative Breast Cancer (TNBC), Colorectal Cancer, Urothelial Cancer
Context Therapeutics Inc.
Phase 1
162
Wahroonga, Gold Coast, Newcastle, Perth
2026-09
Not yet open
Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
NCT07718737NSCLC (Advanced Non-small Cell Lung Cancer)
DrugsAMT-116·Ramucirumab·Docetaxel
Multitude Therapeutics Inc.
Phase 2/3
512
Coffs Harbour, Melbourne, Newcastle, Sydney
2026-08-28
Recruiting
Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
NCT07606352IgAN
DrugSTL303
Sitala Bio LTD
Phase 2
15
Newcastle, Penrith, Sydney, Woolloongabba, Clayton, Saint Albans, Perth
2026-08-04
Not yet open
Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
NCT07323095Chronic Kidney Disease
DrugsABP-671·Febuxostat
Atom Therapeutics Co., Ltd
Phase 2
80
Gosford, Newcastle, Brisbane
2026-06-30
Not yet open
A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer
NCT06476639Vulvar Cancer Stage I, Vulvar Cancer Stage II, Lymph Node Metastasis, Groin Node
Queensland Centre for Gynaecological Cancer
Phase 3
640
Newcastle, Darwin, Auchenflower, Brisbane, Buderim, Adelaide, Heidelberg, Parkville
2026-06-01
Recruiting
Intratumoral N17350 in Advanced Solid Tumors
NCT07339176Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative, Squamous Cell Carcinoma of Skin, Melanoma
Onchilles Pharma Inc
Phase 1/2
275
Newcastle, Westmead, Melbourne
2026-05-25
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
DrugsABP-745 A·ABP-745 B
Atom Therapeutics Co., Ltd
Phase 2
200
Newcastle, Morayfield, Brisbane, Wahroonga
2026-04-23
Not yet open
GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer
NCT07465172Breast Cancer
Breast Cancer Trials, Australia and New Zealand
Not applicable
150
Newcastle, Melbourne
2026-03
Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
NCT07174336Breast Neoplasms, Neoplasm Metastasis
DrugsTersolisib·Exemestane·Anastrozole·Ribociclib
Eli Lilly and Company
Phase 3
800
Ballarat Central, Brisbane, Darlinghurst, Hobart, Melbourne, Newcastle, North Ryde, Shepparton
2025-12-22
Recruiting
PRIORITY-CONNECT 2 Trial
NCT06976710Colorectal Cancer, Colorectal Neoplasms
Surgical Outcomes Research Centre (SOuRCe)
Not applicable
564
Coffs Harbour, Newcastle, Sydney, Wagga Wagga, Wollongong, Brisbane, Adelaide, Ballarat
2025-10-15
Recruiting
Safety, Tolerability and Efficacy of Adjunctive TBO-309 in Reperfusion for Stroke With Tandem Occlusion
NCT06813651Ischemic Stroke, Tandem Occlusion
DrugTBO-309
ThromBio Pty. Ltd.
Phase 2
78
Newcastle, St Leonards
2025-10-04
Recruiting
The Multicentre Selective Lymphadenectomy Trial - 3
NCT07049276Cutaneous Melanoma, Stage III
Melanoma Institute Australia
Not applicable
1,500
Newcastle, Wollstonecraft, Murdoch
2025-10-01
Active, closed
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
NCT07159763Influenza
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3
10,000
Botany, Maroubra, Merewether, Newcastle, Saint Leonards, St Leonards, Brisbane, Milton
2025-09-25
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
NCT07145229Acute Gouty Arthritis, Gout Flare, Gout Flares, Acute Gout Flare
DrugsABP-745 A·ABP-745 B·Colchicine
Atom Therapeutics Co., Ltd
Phase 2
380
Botany, Brookvale, Kotara, Newcastle, Camberwell, North Altona
2025-08-26
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
NCT06782490Multiple Sclerosis Spasticity
DrugIrafamdastat
Celgene
Phase 2
200
Newcastle, Sydney, Kent Town, Box Hill, Heidelberg, Parkville, Nedlands
2025-06-05
Recruiting
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT06637332Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia, S. Aureus Bloodstream Infection
DrugsDaptomycin·Vancomycin
Todd C. Lee MD MPH FIDSA
Phase 4
300
Blacktown, Concord, Newcastle, Westmead, Herston, Bedford Park, Berwick, Box Hill
2024-11-14
Recruiting
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
NCT06462729Degenerative Disc Disease, Lumbar Disc Disease, Spine Disease, Lumbar Spine Degeneration
Locate Bio Pty Ltd
Phase 1/2
40
Newcastle
2024-11-12
Active, closed
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
NCT06598462Eosinophilic Esophagitis (EoE)
DrugSolrikitug
Uniquity One (UNI)
Phase 2
184
Newcastle, Maroochydore, South Brisbane, Woolloongabba, Box Hill, Fitzroy, Parkville, Murdoch
2024-10-16
Not yet open
Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke
NCT06495671Ischemic Stroke, Stroke
University of Melbourne
Not applicable
30
Newcastle, St Leonards, Adelaide, Melbourne, Parkville
2024-08-01
Recruiting
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
NCT06208657Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Recurrent Cancer
DrugsPaxalisib·Opdualag·Temozolomide·Irinotecan
Australian & New Zealand Children's Haematology/Oncology Group
Phase 1/2
90
Newcastle, Sydney, Brisbane, Adelaide, Hobart, Melbourne, Perth
2024-07-10
Recruiting
An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects
NCT04112992Limb Fracture, Bone Loss
AO Innovation Translation Center
Observational
600
Newcastle
2024-07-03
Active, closed
Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
NCT06125951Dementia Moderate, Dementia, Mild, Alzheimer Disease
Actinogen Medical
Phase 2/3
247
Darlinghurst, Erina, Kogarah, Macquarie Park, Newcastle, Birtinya, Chermside, Bedford Park
2024-04-12
By invitation
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
NCT05932615Aortic Valve Stenosis, Heart Valve Diseases, Aortic Valve Disease, Heart Disease Structural Disorder
Abbott Medical Devices
Not applicable
1,500
Newcastle, Adelaide, Clayton, Melbourne
2024-03-15
Active, closed
A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
NCT05883956Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Patient Preference
DrugsDecitabine·Azacitidine
Otsuka Australia Pharmaceutical Pty Ltd
Phase 3
13
Newcastle, Benowa, Townsville, North Adelaide, Ballarat Central, Traralgon
2023-12-20
Recruiting
AusCADASIL: An Australian Cohort of CADASIL
NCT06148051Cadasil
Perminder Sachdev
Observational
300
Newcastle, Sydney, Brisbane, Melbourne
2023-11-25
Recruiting
A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH
NCT05945537Metabolic Dysfunction-Associated Steatohepatitis
Inipharm Australia Pty Ltd
Phase 1
168
Camperdown, Campbelltown, Newcastle, Saint Leonards, Woolloongabba, Birtinya, Bedford Park, Box Hill
2023-09-08
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
NCT05855200Colonic Neoplasms, Neoplasms, Colon
DrugsCapeox·Dostarlimab·Folfox
GlaxoSmithKline
Phase 3
892
Newcastle, St Leonards, Woolangabba, Heidelberg, Melbourne
2023-08-01
Recruiting
Individualised Blood Pressure Targets Versus Standard Care Among Critically Ill Patients With Shock
NCT05850962Critical Illness, Shock
Rakshit Panwar
Not applicable
1,260
Newcastle
2023-07-20
Active, closed
Ultra Low Frequency Spinal Cord Stimulation for Chronic Low Back Pain
NCT05837234Chronic Pain, Chronic Low-back Pain
Presidio Medical, Inc
Not applicable
55
Newcastle, Wayville, Clayton
2023-05-09
Active, closed
Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System
NCT05501873Atrial Fibrillation
Boston Scientific Corporation
Observational
1,173
Brisbane, Murdoch, Newcastle
2023-03-24
Recruiting
Precision Medicine for Every Child With Cancer
NCT05504772Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Childhood Leukemia
Australian & New Zealand Children's Haematology/Oncology Group
Observational
3,500
Adelaide, Brisbane, Hobart, Melbourne, Newcastle, Perth, Sydney
2022-12-16
Recruiting
Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
NCT05340582Patent Ductus Arteriosus After Premature Birth
DrugsIbuprofen·Acetaminophen
Mount Sinai Hospital, Canada
Phase 2
310
Newcastle, St Leonards
2022-12-12
Recruiting
Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
NCT05393791Prostatic Neoplasms, Castration-Resistant
DrugsZytiga·Xtandi·Abiraterone acetate·Enzalutamide
Leiden University Medical Center
Phase 2
168
Albury, Camperdown, Kogarah, Newcastle, St Leonards, Wahroonga, Birtinya, South Brisbane
2022-11-10
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
NCT05243797Multiple Myeloma
DrugsTeclistamab·Lenalidomide
European Myeloma Network B.V.
Phase 3
1,594
Adelaide, Birtinya, Douglas, Geelong, Melbourne, Newcastle, Sydney
2022-09-08
Active, closed
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
NCT05327530Locally Advanced or Metastatic Urothelial Carcinoma
DrugsAvelumab·Sacituzumab Govitecan
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Bedford Park, Footscray, Kurralta Park, Liverpool, Newcastle, Southport, Sydney, Westmead
2022-08-17
Recruiting
A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study
NCT06290505Esophageal Cancer
DrugDurvalumab
Australasian Gastro-Intestinal Trials Group
Phase 2
54
Garran, Albury, Newcastle, Herston, Bedford Park, Fitzroy, Melbourne, Nedlands
2021-12-08
Recruiting
Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
NCT05105633Basilar Artery Occlusion
DrugTenecteplase
University of Melbourne
Phase 2/3
688
Bankstown, Newcastle, Sydney, Gold Coast, Woolloongabba, Adelaide, Melbourne, Murdoch
2021-11-29
Active, closed
A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)
NCT04980872PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)
Merck Sharp & Dohme LLC
Phase 2
60
Newcastle, Bundaberg
2021-11-02
Recruiting
Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
NCT04903782Neoplastic Syndromes, Hereditary, Cancer, Genetic Predisposition to Disease
Sydney Children's Hospitals Network
Observational
270
Newcastle, Sydney
2021-03-08
Active, closed
Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients
NCT04385732Melanoma, Skin Cancer, Anxiety and Fear
Melanoma and Skin Cancer Trials Limited
Not applicable
670
Camperdown, Newcastle, Sydney, Wollstonecraft, Brisbane, Cairns, Townsville, Bendigo
2021-03-03
Recruiting
Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment
NCT04434807Intra Cerebral Hemorrhage, Stroke
University of Melbourne
Not applicable
240
Newcastle, Sydney, Brisbane, Southport, Adelaide, Melbourne, Parkville
2020-11-15
Active, closed
Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
NCT04419402Metastatic Castration-Resistant Prostate Cancer
DrugsXtandi·Pluvicto·Enzalutamide
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2
162
Camperdown, Darlinghurst, Kogarah, Liverpool, Macquarie Park, Newcastle, Sydney, Brisbane
2020-08-17
Active, closed
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
NCT04136353Prostate Cancer
DrugDarolutamide
University of Sydney
Phase 3
1,100
Albury, Gosford, Newcastle, Nowra, Sydney, Wollongong, Brisbane, Herston
2020-03-31
Active, closed
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
NCT04091126Multiple Myeloma
DrugsBelantamab mafodotin·Bortezomib·Lenalidomide·Dexamethasone
GlaxoSmithKline
Phase 1
118
Newcastle, Clayton, Fitzroy
2019-12-18
Recruiting
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393Stroke, Atrial Fibrillation
DrugsNon-Vitamin K Anticoagulant·NOAC·Dabigatran·Edoxaban
Population Health Research Institute
Phase 4
2,270
Garran, Bankstown, Camperdown, Concord, Liverpool, Newcastle, Westmead, Birtinya
2019-06-14
Recruiting
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
NCT05651347Fetal Growth Retardation, Stillbirth and Fetal Death, Pregnancy Preterm
DrugMelatonin
Monash University
Phase 3
336
Camperdown, Newcastle, South Brisbane, Southport, North Adelaide, Clayton, Heidelberg, Parkville
2019-05-29
Recruiting
Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk
NCT04029363Mitral Regurgitation
HighLife SAS
Not applicable
120
Darlinghurst, Newcastle, Sydney, Auchenflower, Adelaide, Brisbane, Heidelberg, Melbourne
2019-05-28
By invitation
Zoledronate In the Prevention of Paget's Disease: Long Term Extension
NCT03859895Paget Disease
University of Edinburgh
Observational
287
Geelong, Nedlands, Newcastle, Sydney, Toowoomba
2019-04-05
Recruiting
The EXCEL Registry of Patients Requiring ECMO
NCT03793257Critically Ill, Acute Respiratory Failure, Acute Heart Failure, Cardiac Arrest
Australian and New Zealand Intensive Care Research Centre
Observational
3,000
Canberra, Camperdown, Darlinghurst, Liverpool, Newcastle, St Leonards, Sydney, Westmead
2019-02-01
Active, closed
PRecISion Medicine for Children With Cancer
NCT03336931Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Childhood Leukemia
Sydney Children's Hospitals Network
Observational
550
Newcastle, Sydney, Brisbane, Adelaide, Melbourne, Perth
2017-09-05
Active, closed
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
NCT02889874Early Stage Breast Carcinoma
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,167
Canberra, Campbelltown, Camperdown, Darlinghurst, Gateshead, Gosford, Liverpool, Newcastle
2017-08-21
Active, closed
REDUCE LAP-HF TRIAL II
NCT03088033Heart Failure
Corvia Medical
Not applicable
608
Camperdown, Newcastle, Sydney, Brisbane, Melbourne
2017-06-01
Active, closed
A Study of LY3200882 in Participants With Solid Tumors
NCT02937272Solid Tumor
DrugsNab-paclitaxel·Gemcitabine·Cisplatin
Eli Lilly and Company
Phase 1
223
Newcastle, Sydney, Greenslopes
2016-11-21
Active, closed
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
NCT02568267Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Head and Neck Neoplasms
DrugEntrectinib
Hoffmann-La Roche
Phase 2
534
Liverpool, Newcastle, Bedford Park, Heidelberg
2015-11-19
Active, closed
A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
NCT02099123Independent Living, Disability Free Survival, Elderly, Healthy
DrugsLipitor·Atorvastatin
Monash University
Phase 4
9,971
Hobart, Melbourne, Adelaide, Brisbane, Newcastle, Perth
2015-07
Recruiting
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
NCT02582697Germ Cell Tumor
DrugsFilgrastim·Pegfilgrastim·Bleomycin·Etoposide
University of Sydney
Phase 3
500
Newcastle, St Leonards, Sydney, Wahroonga, Brisbane, South Brisbane, Woolloongabba, Adelaide
2014-02
Active, closed
Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
NCT01924819Gastric Cancer
DrugsEpirubicin·Leucovorin·Adrucil·Docetaxel
Australasian Gastro-Intestinal Trials Group
Phase 2/3
574
Newcastle, Sydney, Tweed Heads, Wollongong, Brisbane, Adelaide, Hobart, Launceston
2009-09
Active, closed
Radiotherapy - Adjuvant Versus Early Salvage
NCT00860652Prostate Cancer
Trans Tasman Radiation Oncology Group
Not applicable
333
Campbelltown, Camperdown, Coffs Harbour, Darlinghurst, Kingswood, Kogarah, Liverpool, Newcastle
2009-03-03
Active, closed
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
NCT00310180Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7
DrugsTamoxifen Citrate·Exemestane·Anastrozole·Letrozole
National Cancer Institute (NCI)
Phase 3
10,273
Albury, Coffs Harbour, Concord, Lismore, Merewether, Newcastle, Waratah, Herston
2006-04-07
Recruiting
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)
NCT01704716Neuroblastoma
DrugsEndoxan·Dinutuximab·Filgrastim·G-Csf
St. Anna Kinderkrebsforschung
Phase 3
3,300
Adelaide, Brisbane, Newcastle, Parkville, Sydney, Westmead
2002-02
Rows per page Showing 1–60 of 60
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-australia/city/newcastle

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,331 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 60 of those studies with a site in Newcastle.

How many clinical trials are recruiting in Newcastle?

32 of the 60 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 5 have not yet opened recruitment, 21 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Newcastle), 60 studies
PhaseStudiesRecruitingShare
Phase 214823.3%
Not applicable13521.7%
Phase 311618.3%
Observational8513.3%
Phase 1426.7%
Phase 2/3416.7%
Phase 1/2335%
Phase 4325%

Most active sponsors

Lead sponsors with the most studies (Newcastle)
Lead sponsorStudiesRecruiting
Atom Therapeutics Co., Ltd32
University of Melbourne32
Australasian Gastro-Intestinal Trials Group21
Australian & New Zealand Children's Haematology/Oncology Group22
Breast Cancer Trials, Australia and New Zealand20
Eli Lilly and Company21
GlaxoSmithKline21
Monash University21
Sydney Children's Hospitals Network21
University of Sydney21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.